flow trial semaglutide all-cause mortality hazard ratio Effects of with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the Effects of Semaglutide on Stroke

America's Poison Centers released the data with a disclaimer that the figures likely represent an undercount in the number of cases involving semaglutide, as the center only included those voluntarily reported to poison control centers

The preclinical and animal studies indicate benefits for tendon and joint injuries, says Drew Timmermans, ND, a naturopathic physician and cofounder of Regenerative Performance in Arizona

it offers pathway-level context for a conversation with your provider

Many of the studies had small sample size and assessed only short-term outcomes

Metformin is first-line treatment for type 2 diabetes, but glifozins and Incretin mimetics may be preferred over Gliptins as add-on therapy based on reductions in all-cause and CV mortality

Prior authorization typically takes 5 to 10 business days, though complex cases can extend to 3 weeks or longer if additional clinical information is requested